子宫托治疗盆腔器官脱垂临床疗效及对生活质量的影响  

Impacts of Pessary on the Clinical Effect and Life Quality of the Women with Pelvic Organ Prolepses

作　　者：杨将[1,2] 李环[2] 胡艳[1] 肖爱民[1] 马喆[1] 

机构地区：[1]安徽医科大学北大深圳医院临床学院,广东深圳518036 [2]北京大学深圳医院妇科深圳市女性重大疾病诊断实验室,广东深圳518036

出　　处：《罕少疾病杂志》2014年第3期38-42,共5页Journal of Rare and Uncommon Diseases

摘　　要：目的评估子宫托治疗盆腔器官脱垂(POP)的临床效果及对患者生活质量影响。方法对2012年2月至2014年1月就诊于北京大学深圳医院妇科门诊并使用子宫托的POP患者进行电话随访,填写患者盆底症状影响量表PFDI-20、生活影响量表(PFIQ-7)的部分内容,采集患者子宫托使用情况。采用配对秩和检验对患者子宫托治疗前后进行检验及效果评估。结果共有46例患者采用子宫托治疗,其中,32例完成随访,占69.56%,治疗前症状影响量表总体评分为19(3-30),治疗后总体评分为5(0-30),P值<0.05;生活质量影响量表治疗前总体评分为12(0-33),治疗后评分为0.50(0-32),P<0.05,治疗成功率为84%。结论子宫托可以明显改善患者的临床症状,并明显提高患者的生活质量。Objective The purpose of this study was to evaluate the efficiency of pessary in relieving the symptoms and improving the life quality of the women with pelvic organ prolepses （POP）. Methods The patients, who were instructed to use pessaries for treating POP, were followed up by phone and finished part of two condition-specific quality-of-life questionnaires： Pelvic Floor Distress Inventory-20 （PFDI-20） and Pelvic Floor Impact Questionnaire-7（PFIQ-7） after 3 and 6 months’treatment. Wilcoxon’s rank sum test was used to evaluate the clinical effect. Results The pessaries were fitted in 46 patients from February, 2012 to January, 2014. 14 women were lost to follow-up. The remaining 32 patients （69.56%, median age 71 years） completed the study. Five women （15.6 2%） chose not to continue with the pessary treatment. In those who continued treatment, the general score of decreased from a median NRS of 19 （3-30） to 5 （0-30, p〈0.05） from a median NRS of 12 （0-33） to 0.50 （0-32, p〈0.05） after pessary treatment for 3 or 6 months. No woman complained to have relevant complications after pessary treatment. Conclusions Treatment with pessaries might be a feasible treatment option to relieve the symptoms and improve the life quality for women who suffered from POP.

关 键 词：子宫托 盆腔器官脱垂(POP) 

分 类 号：R711.2[医药卫生—妇产科学]